{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:06:51Z","timestamp":1784380011018,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40122-025-00776-w","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T02:02:19Z","timestamp":1760666539000},"page":"1879-1898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and Safety of Mirogabalin as an Add-on to Nonsteroidal Anti-inflammatory Drugs for Neuropathic Pain Caused by Lumbar Disc Herniation: A Randomized Controlled Study (Miro-Hers)"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3156-0591","authenticated-orcid":false,"given":"Hidenori","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kaito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"776_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00264-018-4247-6","volume":"43","author":"T Benzakour","year":"2019","unstructured":"Benzakour T, Igoumenou V, Mavrogenis AF, Benzakour A. Current concepts for lumbar disc herniation. Int Orthop. 2019;43:841\u201351.","journal-title":"Int Orthop"},{"key":"776_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12178-017-9441-4","volume":"10","author":"RM Amin","year":"2017","unstructured":"Amin RM, Andrade NS, Neuman BJ. Lumbar Disc Herniation. Curr Rev Musculoskelet Med. 2017;10:507\u201316.","journal-title":"Curr Rev Musculoskelet Med"},{"key":"776_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12877-020-01738-x","volume":"20","author":"H Liu","year":"2020","unstructured":"Liu H, Jiao J, Zhu C, et al. Potential associated factors of functional disability in Chinese older inpatients: a multicenter cross-sectional study. BMC Geriatr. 2020;20:319.","journal-title":"BMC Geriatr"},{"key":"776_CR4","doi-asserted-by":"publisher","first-page":"1147254","DOI":"10.3389\/fpsyg.2023.1147254","volume":"14","author":"D Ionescu","year":"2023","unstructured":"Ionescu D, Iacob CI, Brehar FM, Avram E. The role of catastrophizing and basic psychological needs satisfaction on health-related quality of life and pain in patients with lumbar disc herniation. Front Psychol. 2023;14:1147254.","journal-title":"Front Psychol"},{"key":"776_CR5","unstructured":"Japanese Orthopaedic Association (JOA) Clinical Practice Guidelines on the Management of Lumbar disc herniation, third edition. Nankodo. 2021. Available from https:\/\/minds.jcqhc.or.jp\/common\/wp-content\/plugins\/pdfjs-viewer-shortcode\/pdfjs\/web\/viewer.php?file=https:\/\/minds.jcqhc.or.jp\/common\/summary\/pdf\/c00645.pdf&dButton=false&pButton=false&oButton=false&sButton=true#zoom=auto&pagemode=none&_wpnonce=3b871a512b. Accessed 12 May 2025."},{"key":"776_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jos.2021.07.028","volume":"27","author":"H Haro","year":"2022","unstructured":"Haro H, Ebata S, Inoue G, et al. Japanese Orthopaedic Association (JOA) clinical practice guidelines on the management of lumbar disc herniation, third edition \u2013 secondary publication. J Orthop Sci. 2022;27:31\u201378.","journal-title":"J Orthop Sci"},{"key":"776_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.spinee.2013.08.003","volume":"14","author":"DS Kreiner","year":"2014","unstructured":"Kreiner DS, Hwang SW, Easa JE, et al. An evidence-based clinical guideline for the diagnosis and treatment of lumbar disc herniation with radiculopathy. Spine J. 2014;14:180\u201391.","journal-title":"Spine J"},{"key":"776_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1185\/03007995.2010.534446","volume":"27","author":"B Morlion","year":"2011","unstructured":"Morlion B. Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components. Curr Med Res Opin. 2011;27:11\u201333.","journal-title":"Curr Med Res Opin"},{"key":"776_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/17453676808989446","volume":"39","author":"I Goldie","year":"1968","unstructured":"Goldie I. A clinical trial with indomethacin (indomeeI) in low back pain and sciatica. Acta Orthop Scand. 1968;39:117\u201328.","journal-title":"Acta Orthop Scand"},{"key":"776_CR10","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/00007632-199309010-00006","volume":"18","author":"H Weber","year":"1993","unstructured":"Weber H, Holme I, Amlie E. The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. Spine (Phila Pa 1976). 1993;18:1433\u20138.","journal-title":"Spine (Phila Pa 1976)"},{"key":"776_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.pain.2010.04.013","volume":"150","author":"R Baron","year":"2010","unstructured":"Baron R, Freynhagen R, T\u00f6lle TR, et al. The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy. Pain. 2010;150:420\u20137.","journal-title":"Pain"},{"key":"776_CR12","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1614292","volume":"376","author":"S Mathieson","year":"2017","unstructured":"Mathieson S, Maher CG, McLachlan AJ, et al. Trial of pregabalin for acute and chronic sciatica. N Engl J Med. 2017;376:1111\u201320.","journal-title":"N Engl J Med"},{"key":"776_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.22603\/ssrr.2018-0003","volume":"3","author":"H Nakashima","year":"2018","unstructured":"Nakashima H, Kanemura T, Ando K, et al. Is pregabalin effective against acute lumbar radicular pain? Spine Surg Relat Res. 2018;3:61\u20136.","journal-title":"Spine Surg Relat Res"},{"key":"776_CR14","first-page":"487","volume":"8","author":"T Taguchi","year":"2015","unstructured":"Taguchi T, Igarashi A, Watt S, et al. Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan. J Pain Res. 2015;8:487\u201397.","journal-title":"J Pain Res"},{"key":"776_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5387\/fms.2013-22","volume":"60","author":"N Takahashi","year":"2014","unstructured":"Takahashi N, Arai I, Kayama S, et al. Therapeutic efficacy of pregabalin in patients with leg symptoms due to lumbar spinal stenosis. Fukushima J Med Sci. 2014;60:35\u201342.","journal-title":"Fukushima J Med Sci"},{"key":"776_CR16","doi-asserted-by":"publisher","first-page":"5079675","DOI":"10.1155\/2016\/5079675","volume":"2016","author":"S Orita","year":"2016","unstructured":"Orita S, Yamashita M, Eguchi Y, et al. Pregabalin for refractory radicular leg pain due to lumbar spinal stenosis: a preliminary prospective study. Pain Res Manag. 2016;2016:5079675.","journal-title":"Pain Res Manag"},{"key":"776_CR17","unstructured":"Mirogabalin besylate (Tarlige\u00ae) tablets [package insert, version 9]. Daiichi Sankyo Co., Ltd.; Tokyo, Japan: 2025. Available from: https:\/\/pins.japic.or.jp\/pdf\/newPINS\/00070625.pdf [In Japanese]. Accessed 3 Mar 2025."},{"key":"776_CR18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/j.pain.0000000000001501","volume":"160","author":"J Kato","year":"2019","unstructured":"Kato J, Matsui N, Kakehi Y, Murayama E, Ohwada S, Sugihara M. Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients. Pain. 2019;160:1175\u201385 (Erratum in: Pain. 2019; 160:1905).","journal-title":"Pain"},{"key":"776_CR19","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/jdi.13013","volume":"10","author":"M Baba","year":"2019","unstructured":"Baba M, Matsui N, Kuroha M, Wasaki Y, Ohwada S. Mirogabalin for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase III study in Asian patients. J Diabetes Investig. 2019;10:1299\u2013306.","journal-title":"J Diabetes Investig"},{"key":"776_CR20","doi-asserted-by":"publisher","first-page":"e1193","DOI":"10.1212\/WNL.0000000000201709","volume":"100","author":"T Ushida","year":"2023","unstructured":"Ushida T, Katayama Y, Hiasa Y, et al. Mirogabalin for central neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled, phase 3 study in Asia. Neurology. 2023;100:e1193\u2013206.","journal-title":"Neurology"},{"key":"776_CR21","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s40122-023-00513-1","volume":"12","author":"T Ushida","year":"2023","unstructured":"Ushida T, Katayama Y, Hiasa Y, et al. Long-term safety and efficacy of mirogabalin for central neuropathic pain: a multinational, phase 3, 52-week, open-label study in Asia. Pain Ther. 2023;12:963\u201378.","journal-title":"Pain Ther"},{"key":"776_CR22","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s40122-022-00410-z","volume":"11","author":"T Nikaido","year":"2022","unstructured":"Nikaido T, Takatsuna H, Tabata S, Shiosakai K, Nakatani T, Konno SI. Efficacy and safety of add-on mirogabalin to NSAIDs in lumbar spinal stenosis with peripheral neuropathic pain: a randomized, open-label study. Pain Ther. 2022;11:1195\u2013214 (Erratum in: Pain Ther. 2022; 11:1215\u20137).","journal-title":"Pain Ther"},{"key":"776_CR23","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s40122-025-00722-w","volume":"14","author":"T Hirai","year":"2025","unstructured":"Hirai T, Okawa A, Takahashi H, Shiosakai K, Yoshii T. Efficacy and safety of mirogabalin in patients with neuropathic pain due to cervical spondylotic radiculopathy: Miro-cens, a randomized, controlled, interventional study. Pain Ther. 2025;14:1063\u201379.","journal-title":"Pain Ther"},{"key":"776_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.31616\/asj.2020.0136","volume":"15","author":"K Kim","year":"2021","unstructured":"Kim K, Isu T, Kokubo R, et al. Therapeutic effect of Mirogabalin on peripheral neuropathic pain due to lumbar spine disease. Asian Spine J. 2021;15:349\u201356.","journal-title":"Asian Spine J"},{"key":"776_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10120996","volume":"10","author":"FN Bittmann","year":"2020","unstructured":"Bittmann FN, Dech S, Aehle M, Schaefer LV. Manual muscle testing-force profiles and their reproducibility. Diagnostics. 2020;10:996.","journal-title":"Diagnostics"},{"key":"776_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bja\/aen103","volume":"101","author":"H Breivik","year":"2008","unstructured":"Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. Br J Anaesth. 2008;101:17\u201324.","journal-title":"Br J Anaesth"},{"key":"776_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","volume":"108","author":"D Bouhassira","year":"2004","unstructured":"Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the neuropathic pain symptom inventory. Pain. 2004;108:248\u201357.","journal-title":"Pain"},{"key":"776_CR28","unstructured":"Clinical Outcomes Committee of the Japanese Orthopaedic Association, Subcommittee on Evaluation of Back Pain and Cervical Myelopathy; Subcommittee on Low Back Pain and Cervical Myelopathy Evaluation of the Clinical Outcome Committee of the Japanese Orthopaedic Association; Fukui M, et al. JOA back pain evaluation questionnaire: initial report. J Orthop Sci. 2007; 12:443\u201350."},{"key":"776_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00776-008-1213-y","volume":"13","author":"M Fukui","year":"2008","unstructured":"Fukui M, Chiba K, Kawakami M, et al. Japanese Orthopaedic Association Back Pain Evaluation Questionnaire. Part 3. Validity study and establishment of the measurement scale: Subcommittee on Low Back Pain and Cervical Myelopathy Evaluation of the Clinical Outcome Committee of the Japanese Orthopaedic Association, Japan. J Orthop Sci. 2008;13:173\u20139.","journal-title":"J Orthop Sci"},{"key":"776_CR30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s00776-007-1168-4","volume":"12","author":"M Fukui","year":"2007","unstructured":"Fukui M, Chiba K, Kawakami M, et al. Japanese Orthopaedic Association Back Pain Evaluation Questionnaire. Part 2. Verification of its reliability: The Subcommittee on Low Back Pain and Cervical Myelopathy Evaluation of the Clinical Outcome Committee of the Japanese Orthopaedic Association. J Orthop Sci. 2007;12:526\u201332.","journal-title":"J Orthop Sci"},{"key":"776_CR31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00776-009-1337-8","volume":"14","author":"M Fukui","year":"2009","unstructured":"Fukui M, Chiba K, Kawakami M, et al. JOA Back Pain Evaluation Questionnaire (JOABPEQ)\/JOA Cervical Myelopathy Evaluation Questionnaire (JOACMEQ). The report on the development of revised versions. April 16, 2007. The Subcommittee of the Clinical Outcome Committee of the Japanese Orthopaedic Association on Low Back Pain and Cervical Myelopathy Evaluation. J Orthop Sci. 2009;14:348\u201365.","journal-title":"J Orthop Sci"},{"key":"776_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00776-009-1426-8","volume":"15","author":"S Ohtori","year":"2010","unstructured":"Ohtori S, Ito T, Yamashita M, et al. Evaluation of low back pain using the Japanese Orthopaedic Association Back Pain Evaluation Questionnaire for lumbar spinal disease in a multicenter study: differences in scores based on age, sex, and type of disease. J Orthop Sci. 2010;15:86\u201391.","journal-title":"J Orthop Sci"},{"key":"776_CR33","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727\u201336.","journal-title":"Qual Life Res"},{"key":"776_CR34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.spinee.2016.02.049","volume":"16","author":"HJ Kim","year":"2016","unstructured":"Kim HJ, Kim JH, Park YS, et al. Comparative study of the efficacy of limaprost and pregabalin as single agents and in combination for the treatment of lumbar spinal stenosis: a prospective, double-blind, randomized controlled non-inferiority trial. Spine J. 2016;16:756\u201363.","journal-title":"Spine J"},{"key":"776_CR35","first-page":"66","volume":"6","author":"YL Lo","year":"2014","unstructured":"Lo YL, Cheong PW, George JM, et al. Pregabalin and radicular pain study (PARPS) for cervical spondylosis in a multiracial Asian population. J Clin Med Res. 2014;6:66\u201371.","journal-title":"J Clin Med Res"},{"key":"776_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","volume":"9","author":"RH Dworkin","year":"2008","unstructured":"Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9:105\u201321.","journal-title":"J Pain"},{"key":"776_CR37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00540-018-2501-0","volume":"32","author":"M Sumitani","year":"2018","unstructured":"Sumitani M, Sakai T, Matsuda Y, et al. Executive summary of the clinical guidelines of pharmacotherapy for neuropathic pain: second edition by the Japanese Society of Pain Clinicians. J Anesth. 2018;32:463\u201378.","journal-title":"J Anesth"},{"key":"776_CR38","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11136-015-1108-2","volume":"25","author":"T Shiroiwa","year":"2016","unstructured":"Shiroiwa T, Fukuda T, Ikeda S, et al. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25:707\u201319.","journal-title":"Qual Life Res"},{"key":"776_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.smrv.2013.07.005","volume":"18","author":"T Roth","year":"2014","unstructured":"Roth T, Arnold LM, Garcia-Borreguero D, Resnick M, Clair AG. A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions. Sleep Med Rev. 2014;18:261\u201371.","journal-title":"Sleep Med Rev"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-025-00776-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:20:55Z","timestamp":1763634055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-025-00776-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1007\/s40122-025-00776-w","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hidenori Suzuki, Takashi Kaito, and Hiroaki Nakashima have no conflicts of interest in relation to the submitted work. Hiroshi Takahashi, Shuhei Yamamoto, and Shunsuke Tabata are employees of Daiichi Sankyo Co., Ltd. Hiromitsu Toyoda has received lecture fees from Daiichi Sankyo Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by Yamaguchi University Certified Review Board (CRB6180002). The study was conducted in accordance with the Clinical Trials Act in Japan, under which clinical research is only required to undergo a central ethical review, as well as the ethical principles and relevant notifications stipulated in the Declaration of Helsinki (as revised in 2013). This study was registered in the Japan Registry of Clinical Trials under the identifier jRCTs061220102. All participants provided informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}